Facts, Not Fear
Finding out you have a pelvic mass can be intimidating and stressful. Whether you have an unknown mass or are already scheduled for surgery, our tests can help you and your doctor decide on a treatment plan that is best for you. Below are some resources to support you in that journey.
Get the Facts on Pelvic Masses
What is a Pelvic or Adnexal Mass?
A pelvic mass or adnexal mass is a growth that develops around the uterus, ovaries, or fallopian tubes. These masses are relatively common, and most are non-cancerous (benign).7,8 However, it's essential to evaluate adnexal masses carefully to determine if they need further treatment or monitoring.
Adnexal masses can occur for various reasons, including ovarian cysts, fibroid tumors, or, in some cases, ovarian cancer. While many masses are harmless, some may require medical intervention, such as surgery or close monitoring.
How Common Are Adnexal Masses?
Adnexal masses are relatively common, occurring in approximately 1 out of 5 women.9,10,12 The good news is that most pelvic masses are benign and don’t need surgery. Instead, doctors often recommend a “watchful waiting” approach, which means keeping an eye on the mass with regular check-ups and tests. Knowing how common these masses are can help you feel more at ease about your situation.
KNOW THE FACTS
of adnexal masses are benign11
If I have an Adnexal Mass Does This Mean I Have Ovarian Cancer?
Finding a pelvic mass doesn’t mean you have ovarian cancer. In fact, most pelvic masses are non-cancerous. OvaWatch & Ova1 are products that can help assess the risk of ovarian cancer for women with adnexal masses. By giving you a personalized risk score, our tests can help your healthcare provider decide the best next steps for your care, ensuring you get the right treatment and peace of mind.
Why not have surgery as soon as possible?
The removal of the adnexal mass may also involve the removal of one or both ovaries in a surgical procedure called "oophorectomy." There are a variety of reasons besides ovarian cancer risk to proceed to surgery, but it is important to know that removal of the ovaries is a big decision at any age. The removal of the ovaries prior to menopause raises other considerations.6
In those circumstances, removal of both ovaries will likely result in the onset of surgical menopause. It is important to plan for possible changes to your body after surgery.
KNOW THE FACTS
out of 7
What Are My Risk Assessment Options?
If an adnexal mass is detected, your healthcare provider may recommend one of the following products from Aspira Women's Health to help guide your personalized treatment plan. Our OvaSuiteSM portfolio includes:
Not Planned for Immediate Surgery
Learn More →
WATCH & WAIT
OvaWatch is intended for women who have an adnexal mass that has been determined as indeterminate or benign on initial clinical assessment. It provides a personalized risk score to help guide next steps like continued monitoring or surgery.
Planned For Surgery
Learn More →
PLANNED FOR SURGERY
Ova1 is used when surgery is already being considered to remove an adnexal mass. It estimates the ovarian cancer risk to help determine if the surgery can be performed by your gynecologist, or if sending to a gynecologic oncologist is more appropriate.
What to Expect
What should I expect when my healthcare provider orders an OvaSuite test?
BEFORE THE TEST
Before taking an OvaSuite test, your healthcare provider will explain how it works and why it’s being done. The test involves a simple blood draw, which can be done at your doctor’s office or a local lab.
DURING THE TEST
The blood draw is quick and usually only involves a little discomfort. Your blood sample will be sent to a specialized lab for analysis.
AFTER THE TEST
Results are typically ready within 48 hours. Your healthcare provider will go over the results, Depending on your score, your provider might suggest more monitoring, additional tests, or a referral to a specialist.
Insurance and Financial Assistance
Aspira Women’s Health accepts most insurance plans including Commercial, Medicaid plans, Medicare/Medicare Advantage.
If you have an adnexal mass, the first step is OvaWatch or Ova1Plus. Ask your doctor today about our simple, non-invasive blood tests that can assess your ovarian cancer risk.
Additional Resources We Trust
PRECAUTION:
OVAWATCH IS INTENDED FOR USE AS A NON-INVASIVE TEST TO ASSESS THE RISK OF OVARIAN CANCER FOR WOMEN WITH ADNEXAL MASSES, EVALUATED BY INITIAL CLINICAL ASSESSMENT (ICA) AS INDETERMINATE OR BENIGN. IN CONJUNCTION WITH IMAGING (ULTRASOUND AND/OR CT) AND CLINICAL ASSESSMENT, THIS TEST WILL SUPPORT PHYSICIANS IN MAKING INFORMED CLINICAL DECISIONS IN THE MANAGEMENT OF WOMEN WITH ADNEXAL MASSES. THE TEST IS NOT INTENDED AS A SCREENING TEST OR A STAND-ALONE DIAGNOSTIC ASSAY.
OVA1 AND OVERA SHOULD NOT BE USED WITHOUT AN INDEPENDENT CLINICAL AND IMAGING EVALUATION AND IS NOT INTENDED TO BE A SCREENING TEST OR TO DETERMINE WHETHER A PATIENT SHOULD PROCEED TO SURGERY. INCORRECT USE CARRIES THE RISK OF UNNECESSARY TESTING, SURGERY, AND/OR DELAYED DIAGNOSIS.